| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |